Lung Cancers Withdrawn Phase 1 / 2 Trials for Sirolimus (DB00877)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Withdrawn1 / 2 IdentifierTitlePurposeDrugs
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment